• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    2/13/23 2:03:18 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADOC alert in real time by email
    SC 13G/A 1 Edoc.txt EDOC ACQUISITION CORP. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No._1)* (Name of Issuer) EDOC ACQUISITION CORP. (Title of Class of Securities) Class A Ordinary Shares, $0.0001 par value (CUSIP Number) G4000A102 (Date of Event Which Requires Filing of this Statement) 12/31/2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. G4000A102 (1) Names of reporting persons Polar Asset Management Partners Inc. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Citizenship or place of organization Ontario, Canada Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power (7) Sole dispositive power 0 (8) Shared dispositive power (9) Aggregate amount beneficially owned by each reporting person 0 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 0.00% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: EDOC ACQUISITION CORP. Item 1(b) Address of issuer's principal executive offices: 7612 Main Street Fishers Suite 200 Victor, NY 2(a) Name of person filing: This statement is filed by Polar Asset Management Partners Inc., a company incorporated under the laws of Ontario, Canada, which serves as the investment advisor to Polar Multi-Strategy Master Fund, a Cayman Islands exempted company ("PMSMF") with respect to the Shares (as defined below) directly held by PMSMF. 2(b) Address or principal business office or, if none, residence: 16 York Street, Suite 2900, Toronto, ON, Canada M5J 0E6. 2(c) Citizenship: Canada 2(d) Title of class of securities: Class A Ordinary Shares, $0.0001 par value 2(e) CUSIP Number: G4000A102 Item 3. [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); [x] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: The Reporting Person is an investment fund manager, portfolio manager, exempt market dealer and commodity trading manager registered with the Ontario Securities Commission. Item 4. Ownership As of December 31, 2022 1. Polar Asset Management Partners Inc. (a) Amount beneficially owned: 0 (b) Percent of class: 0.00% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5.Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]. Instruction. Dissolution of a group requires a response to this item. Item 6. Ownership of More than 5 Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below I certify that, to the best of his/her knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2023 POLAR ASSET MANAGEMENT PARTNERS INC. By: /s/ Andrew Ma Name: Andrew Ma Title: Chief Compliance Officer
    Get the next $ADOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADOC
    SEC Filings

    View All

    SEC Form 15-12G filed by Edoc Acquisition Corp.

    15-12G - Edoc Acquisition Corp. (0001824884) (Filer)

    4/1/24 6:02:12 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    3/28/24 5:16:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 25-NSE filed by Edoc Acquisition Corp.

    25-NSE - Edoc Acquisition Corp. (0001824884) (Subject)

    3/22/24 8:52:21 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

    Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC

    2/27/24 5:32:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination

    Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) --  EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LL

    2/23/24 5:45:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Australian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination

    ~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business CombinationScheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, Australian Oilseeds Investments Pty Ltd. is Expected to Trade on Nasdaq Under the Ticker "COOT" ~ Victor, NY and Cootamundra New South Wales, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Australian Oilseeds" or "Pubco") and EDOC Acquisition Corp., a publicly-traded special purpose acquisition company ("EDOC") (NASDAQ:ADOC, ADOCW, ADOCR))), today announced that the Securities and Exchange Commission ("SEC")

    2/7/24 3:00:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Yakira Capital Management, Inc. disposed of $2,662,742 worth of Class A Ordinary Shares (248,622 units at $10.71)

    4 - Edoc Acquisition Corp. (0001824884) (Issuer)

    2/23/23 5:01:04 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3: New insider Yakira Capital Management, Inc. claimed ownership of 275,000 units of Class A Ordinary Shares

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    1/26/23 2:36:23 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Li Yan Michael

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    11/7/22 5:20:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/24 12:48:37 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/24 4:41:59 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    1/31/24 6:08:55 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care